TRIAL DETAIL
Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Imatinib Mesylate Refractory Advanced/Metastatic Malignant GIST
Drug: |
||||
|---|---|---|---|---|
Trial Name: |
Phase II Trial of Locally Advanced/Metastatic Soft Tissue Sarcoma or Imatinib Mesylate Refractory Advanced/Metastatic Malignant GIST |
|||
NCT#: |
||||
Conditions: |
Sarcoma; Malignant GIST |
|||
Status: |
Completed |
|||
Phase: |
2 |
Start Date 12/01/2006 |
Age of Trial (yrs) 17.4 |
|
Treatment Phase: |
Gleevec-resistant |
|||
Drug Category: |
Chemotherapy |
|||
Strategy: |
Interfere with production of new DNA |
|||
Trial Type: |
Specifically GIST plus other cancers |
|||
Other Protocol IDs: |
T1706 |
|||
Sponsor: |
National Health Research Institutes, Taiwan |
|||
Patient Contact: |
See site contact info below |
|||
Contact email: |
||||
Contact Phone: |
||||
Randomized: |
||||
IV or Oral: |
IV
Intravenous |
|||
Trial Notes: |
||||
Trial Links |
Trial Results |
Drug Information |
| Gemzar.com |
| Taxotere.com |
Trial Sites
Name |
Address |
City |
State |
Zip |
Country |
Taichung |
Taiwan |